Join now & save up to 80% on medication

JOIN NOW
Select Language:

Join now and save 80% on medication

Register/Login

Nesina VS. Januvia

Share Post:

Nesina vs Januvia

Nesina (alogliptin) and Januvia (sitagliptin) are prescription medications that lower blood sugar. Both medications are dipeptidyl peptidase-4 (DPP-4) inhibitors.

What are these medications used for?

Though there are differences between alogliptin and sitagliptin, they are both used to treat type 2 diabetes. They are ideal as add-on medications for patients having difficulty controlling their blood sugar levels. Though not as effective as insulin, Nesina and Januvia help to keep insulin levels stable. For the most effective results, Nesina and Januvia should be used in combination with a regulated diet and exercise.

How to take these drugs

Unlike many other diabetes medications, alogliptin and sitagliptin are taken as oral pills once daily instead of via injection. Each may be taken with or without food.

Nesina and Januvia side effects

While Nesina and Januvia are both safe and effective medications, patients may experience side effects. Patients experiencing severe side effects should contact a doctor immediately.

Common side effects

  • Upper respiratory tract infection
  • Nasopharyngitis
  • Headache

Severe side effects

  • Seizures
  • Blurred vision
  • Dizziness

Dosage

When it comes to alogliptin vs sitagliptin, the biggest difference is the dosage. Though the instructions for taking the medications are the same, the dosage varies. The recommended dose of Nesina is 25 mg taken once daily, while the recommended dosage of Januvia is 100 mg taken once daily.

Doctor’s Recommendation

Due to the fact that both DPP4 inhibitors are able to reduce HBA1C by .5-.8% and have a similar side-effect profile, the drug of choice should be based on which one the patient’s health insurance covers better. 

Disclaimer: Please note that the contents of this community article are strictly for informational purposes and should not be considered as medical advice. This article, and other community articles, are not written or reviewed for medical validity by Canadian Insulin or its staff. All views and opinions expressed by the contributing authors are not endorsed by Canadian Insulin. Always consult a medical professional for medical advice, diagnosis, and treatment.

Medically Reviewed

Profile image of Dr Pawel Zawadzki

Medically Reviewed By Dr Pawel ZawadzkiDr. Pawel Zawadzki, a U.S.-licensed MD from McMaster University and Poznan Medical School, specializes in family medicine, advocates for healthy living, and enjoys outdoor activities, reflecting his holistic approach to health.

Profile image of CDI Staff Writer

Written by CDI Staff WriterOur internal team are experts in many subjects. on October 31, 2019

Related Articles

Diabetes, Diabetes Supplies,
Soliqua Solostar Pen – One Pen, Dual-Action Support

Managing type 2 diabetes can be a complicated journey, especially when your current treatment plan isn’t helping you meet your blood sugar goals. That’s where the Soliqua Solostar Pen comes…

Read More
Cardiovascular Health, Diabetes,
How SGLT2 Inhibitors Are Changing Heart Failure Care

Heart failure is a long-term health condition impacting millions worldwide. It occurs when the heart can’t pump blood efficiently, resulting in symptoms like fatigue, breathlessness, and swelling. Traditionally, treatment has…

Read More
Diabetes, Diabetes Supplies,
Basaglar Cartridge: Long-Acting Insulin for Diabetes

Managing diabetes requires consistent attention, especially when it comes to regulating blood sugar levels. Among the tools used in long-term diabetes care is long-acting insulin, and one notable option is…

Read More
Diabetes, Diabetes Supplies,
Xultophy® Prefilled Pen: Insulin + GLP-1 for Diabetes Care

Managing type 2 diabetes is often a balancing act that involves careful monitoring, lifestyle adjustments, and effective medication. For many patients, finding a treatment that delivers strong blood sugar control…

Read More